跳至主要内容
临床试验/CTRI/2012/08/002930
CTRI/2012/08/002930已完成4 期

An open labeled study of vitamin K2-7 (MK-7) in patients with diabetic peripheral neuropathy and/ or megaloblastic anaemia

Viridis BioPharma Pvt Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Adult male and non-pregnant female patients of the age group 18-60 years
  • 2.Confirmed diagnosis of vitamin B12 deficiency and/or Diabetes Mellitus including pre-diabetics as per WHO criteria
  • 3.Clinical and/or laboratory evidence of peripheral neuropathy
  • 4.No history of drug allergy or significant vitamin K intake
  • 5.Willing to give informed consent

排除标准

  • 1.Any major systemic illness.
  • 2.Glycosylated hemoglobin more than 9 and Sugar Fasting more than 250 mg%
  • 3.Patient who are on anti coagulant drug
  • 4.Patient who are on any concomitant medication of neurotoxic or anti-peresthetic drug
  • 5.Patient with sever acute illness
  • 6.Person who are addicted to alcohol

研究者

发起方
Viridis BioPharma Pvt Ltd

相似试验